Lau, L. de

stroke study patient disease ischemic stroke ischemic parkinson association factor level disorder mutation vitamin trial protein result control coagulation score rotterdam homocysteine ischaemic stroke effect therapy treatment lesion ischaemic coagulation disorders signi group children number brain brinogen participant deficiency table neurol neurology 0.00 plasma aphasia antibody scale concentration antiphospholipid antibodies evidence baseline analysis symptom model activity rotterdam study parkinson disease fatigue severity attack fi ndings prevention thrombosis event polymorphism ficant population research statin risk factors venou signi ficantly antiphospholipid review case –control studies onset matter movement venous thrombosis function status dyskinesia –control